[1]
O. Burianov, L. Khimion, T. Omelchenko, and M. Vakulych, “Evidence, Efficasy and Safety of the Chondroprotective Parapharmaceuticals in Treatment of the Early Stages of Osteoarthritis”, FMEP, no. 2-3, pp. 34–42, Jul. 2021.